You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Adiponectin antibody [MADI 14] (ab78302)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-Adiponectin antibody [MADI 14]
See all Adiponectin products (25) ...

Description

Rat monoclonal [MADI 14] to Adiponectin

Specificity

ab78302 recognizes both natural and recombinant mouse Adiponectin. It shows weak cross-reactivity with human and rat Adiponectin.

Tested applications

WB, IP, ELISA, Indirect ELISAmore details

Cross reactivity

Reacts with

Mouse

Immunogen

Recombinant mouse Adiponectin conjugated to Fc expressed from mammalian cells.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: Ascites

Concentration

Concentration information loading...

Purity

Ascites

Clonality

Monoclonal

Clone number

MADI 14

Isotype

IgG2a

Applications

Show applications key

Our Abpromise guarantee covers the use of ab78302 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • WB

     
  • IP

     
  • ELISA

     
  • Indirect ELISA

     

Application notes

ELISA: 1/5000 - 1/10000.
IP: Use 1-5µl per sample in a final reaction volume of 500-1000µl.
I-ELISA: 1/5000 - 1/10000.
WB: 1/5000 - 1/10000 for 1 hour at room temperature. Predicted molecular weight: 27 kDa.


Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Important adipokine involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic and anti-inflammatory activities. Stimulates AMPK phosphorylation and activation in the liver and the skeletal muscle, enhancing glucose utilization and fatty-acid combustion. Antagonizes TNF-alpha by negatively regulating its expression in various tissues such as liver and macrophages, and also by counteracting its effects. Inhibits endothelial NF-kappa-B signaling through a cAMP-dependent pathway. May play a role in cell growth, angiogenesis and tissue remodeling by binding and sequestering various growth factors with distinct binding affinities, depending on the type of complex, LMW, MMW or HMW.

Tissue specificity

Synthesized exclusively by adipocytes and secreted into plasma.

Involvement in disease

Defects in ADIPOQ are the cause of adiponectin deficiency (ADPND) [MIM:612556]. ADPND results in very low concentrations of plasma adiponectin.
Genetic variations in ADIPOQ are associated with non-insulin-dependent diabetes mellitus (NIDDM) [MIM:125853]; also known as diabetes mellitus type 2. NIDDM is characterized by an autosomal dominant mode of inheritance, onset during adulthood and insulin resistance.

Sequence similarities

Contains 1 C1q domain.
Contains 1 collagen-like domain.

Domain

The C1q domain is commonly called the globular domain.

Post-translational
modifications

Hydroxylated Lys-33 was not identified in PubMed:16497731, probably due to poor representation of the N-terminal peptide in mass fingerprinting.
HMW complexes are more extensively glycosylated than smaller oligomers. Hydroxylation and glycosylation of the lysine residues within the collagene-like domain of adiponectin seem to be critically involved in regulating the formation and/or secretion of HMW complexes and consequently contribute to the insulin-sensitizing activity of adiponectin in hepatocytes.
O-glycosylated. Not N-glycosylated. O-linked glycans on hydroxylysines consist of Glc-Gal disaccharides bound to the oxygen atom of post-translationally added hydroxyl groups. Sialylated to varying degrees depending on tissue. Thr-22 appears to be the major site of sialylation. Higher sialylation found in SGBS adipocytes than in HEK fibroblasts. Sialylation is not required neither for heterodimerization nor for secretion. Not sialylated on the glycosylated hydroxylysines. Desialylated forms are rapidly cleared from the circulation.

Cellular localization

Secreted.

Target information above from: UniProt accessionQ15848 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • C1q and collagen domain-containing protein antibody
  • 30 kDa adipocyte complement related protein antibody
  • 30 kDa adipocyte complement-related protein antibody
  • ACDC antibody
  • ACRP30 antibody
  • ADIPO_HUMAN antibody
  • Adipocyte antibody
  • Adipocyte C1q and collagen domain containing protein antibody
  • Adipocyte complement related 30 kDa protein antibody
  • Adipocyte complement related protein of 30 kDa antibody
  • Adipocyte complement-related 30 kDa protein antibody
  • Adiponectin antibody
  • ADIPOQ antibody
  • Adipose most abundant gene transcript 1 antibody
  • Adipose most abundant gene transcript 1 protein antibody
  • Adipose specific collagen like factor antibody
  • ADIPQTL1 antibody
  • ADPN antibody
  • apM-1 antibody
  • APM1 antibody
  • GBP28 antibody
  • Gelatin binding protein antibody
  • Gelatin binding protein 28 antibody
  • Gelatin-binding protein antibody
see all

Database links

References for Anti-Adiponectin antibody [MADI 14] (ab78302)

ab78302 has not yet been referenced specifically in any publications.

Publishing research using ab78302? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"